Guardant Health

Yahoo Finance • 5 days ago

Merck Deepens Oncology And Vaccine Bets With Partnerships And Equity Stake

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Merck (NYSE:MRK) has taken a significant equity stake in Eikon The... Full story

Yahoo Finance • 6 days ago

Merck Eyes Post Keytruda Growth With Eikon Stake And Guardant Pact

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Merck (NYSE:MRK) has invested $30 million for nearly a 10% stake in Eikon Therapeutics as Eikon mo... Full story

Yahoo Finance • last month

Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside

Guardant Health Inc. (NASDAQ:GH) is one of the hottest large-cap stocks of 2025. On December 22, Canaccord raised the firm’s price target on Guardant Health to $125 from $100 with a Buy rating on the shares. The firm expects the life scien... Full story

Yahoo Finance • last month

Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

PALO ALTO, Calif., December 29, 2025--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in... Full story

Yahoo Finance • 2 months ago

Noteworthy ETF Outflows: ARKG, TEM, TWST, GH

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ARK Genomic Revolution ETF (Symbol: ARKG) where we have detected an approximate $73.5 million dollar outflow... Full story

Yahoo Finance • 2 months ago

Tuesday's ETF Movers: ARKF, XT

In trading on Tuesday, the ARK Fintech Innovation ETF is outperforming other ETFs, up about 1.2% on the day. Components of that ETF showing particular strength include shares of Circle Internet Group, up about 8.6% and shares of Robinhood... Full story

Yahoo Finance • 2 months ago

Guardant Health price target raised to $120 from $100 at BofA

BofA raised the firm’s price target on Guardant Health (GH) to $120 from $100 and keeps a Buy rating on the shares. The firm is updating it price targets for Life Sciences & Diagnostic Tools stocks under its coverage, the analyst tells inv... Full story

Yahoo Finance • 2 months ago

AI adopters trade gaining steam; top stocks in AI adoption sectors

[Digital Intelligence - AI Icon Illuminated Against Financial Data and Binary Streams] J Studios Wall Street research looks to be shifting from endorsing the classic AI trade to AI adopters. Instead of the chipmakers and hyperscalers in... Full story

Yahoo Finance • 3 months ago

LLY joins $1T club but doesn't feature in SA's top 10 large-cap healthcare stocks

[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American... Full story

Yahoo Finance • 3 months ago

Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access

34-member consortium creates an interoperable data standard for AI and distributed analytics Notable founding members include Guardant Health, NetApp, Seagate, IBM, DDN, and Genentech PALO ALTO, Calif., November 12, 2025--(BUSINESS WIRE)-... Full story

Yahoo Finance • 3 months ago

Why Guardant Health Stock Surged Today

Key Points Guardant's oncology and screening businesses are expanding at a rapid pace. New partnerships should drive further gains.10 stocks we like better than Guardant Health › Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher... Full story

Yahoo Finance • 3 months ago

Top Midday Gainers

Guardant Health (GH) shares soared 26% amid heavy trading after the company reported overnight impro PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Guardant Health Non-GAAP EPS of -$0.39 beats by $0.10, revenue of $265.2M beats by $29.51M

* Guardant Health press release [https://seekingalpha.com/pr/20285132-guardant-health-reports-third-quarter-2025-financial-results-and-increases-2025-revenue] (GH [https://seekingalpha.com/symbol/GH]): Q3 Non-GAAP EPS of -$0.39 beats by... Full story

Yahoo Finance • 4 months ago

Guardant Health (GH) Is Up 7.9% After FDA Approval of Blood Test for Lilly’s Inluriyo

Guardant Health received FDA approval for its Guardant360 CDx blood test as a companion diagnostic for Eli Lilly’s Inluriyo, targeting advanced breast cancer patients with ESR1 mutations. This regulatory milestone positions Guardant Health... Full story

Yahoo Finance • 4 months ago

S&P 500's New AI Play? Walmart In Buy Zone, Leads Five Stocks To Watch Amid Volatile Market

S&P 500 giant Walmart and a profitable biotech are actionable, leading five stocks to watch amid a tricky market environment. Continue Reading View Comments... Full story

Yahoo Finance • 4 months ago

Propel Software Accelerates Adoption of Agentic AI for PLM, QMS & PIM with Early Customers Using Live Data

Technology, Medical Device, and Consumer Goods Companies Achieve Business Efficiencies with Propel One Agentic AI Solution REDWOOD CITY, Calif., October 09, 2025--(BUSINESS WIRE)--Propel, creator of the first product value management (PVM... Full story

Yahoo Finance • 4 months ago

GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex

Company Logo The GCC Liquid Biopsy Market is projected to grow from US$ 98.24 million in 2024 to US$ 309.53 million by 2033, at a CAGR of 13.60%. This rapid growth is driven by rising cancer incidence, advances in genomics technology, inc... Full story

Yahoo Finance • 4 months ago

Guardant Health, Inc. (GH) Unveils Shield V2, Boosts Early Cancer Detection Accuracy

We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Guardant Health, Inc. is one of them. Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, specializes in blood-based cancer dia... Full story

Yahoo Finance • 4 months ago

Why Guardant Health (GH) Stock Is Trading Up Today

What Happened? Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion diagnostic for Eli Lilly... Full story

Yahoo Finance • 4 months ago

Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic

[Cancer cells vis] koto_feja Guardant Health (NASDAQ:GH [https://seekingalpha.com/symbol/GH]) has received approval from the U.S. FDA for its Guardant360 CDx, which serves as a companion diagnostic tool. The Guardant360 CDx is specifical... Full story